ClinicalTrials.gov
public full text
Public Domain
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
Hookworms digest hemoglobin from erythrocytes for use as an energy source via a proteolytic cascade that begins with the aspartic protease, APR-1. Vaccination with recombinant APR-1 has protected animals from infection in challenge studies. This study will evaluate the safety and immunogenicity of two formulations of Na-APR-1 (M74) in healthy adult volunteers when co-administered with different concentrations of the immunostimulant GLA-AF.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Induction of Gut Permeability by an Oral Vaccine#888194
- Comparison of total IgG and neutralizing antibody responses to a novel trivalent recombinant<i> Mannheimia</i><i> haemolytica</i> vaccine containing serotype 6#419907
- tjhladish/covid-abm: Active Vaccination Experiment 2023-02-02#677956
- A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine#363651
- Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age#1171873
Record · ID 876846
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive